Results 41 to 50 of about 92,889 (88)

Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody. [PDF]

open access: yesImmunol Lett, 2022
Saavedra D   +13 more
europepmc   +1 more source

Corrigendum. [PDF]

open access: yesImmunotherapy, 2022
europepmc   +1 more source

Neurological Adverse Reactions to SARS-CoV-2 Vaccines. [PDF]

open access: yesClin Psychopharmacol Neurosci, 2023
Finsterer J.
europepmc   +1 more source

Biomarkers of sequela in adult patients convalescing from COVID-19. [PDF]

open access: yesAdv Biomark Sci Technol, 2022
Marsán-Suárez V   +29 more
europepmc   +1 more source

Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study. [PDF]

open access: yesPLoS One, 2023
Venegas-Rodríguez R   +12 more
europepmc   +1 more source

Protein kinase CK2: a potential therapeutic target for diverse human diseases. [PDF]

open access: yesSignal Transduct Target Ther, 2021
Borgo C   +4 more
europepmc   +1 more source

Recent advances in respiratory immunization: A focus on COVID-19 vaccines. [PDF]

open access: yesJ Control Release, 2023
He X, Chen X, Wang H, Du G, Sun X.
europepmc   +1 more source

Home - About - Disclaimer - Privacy